CAS No.94-78-0,3-(PHENYLAZO)-2,6-PYRIDINEDIAMINE Suppliers

Products Categories

Pharmaceutical (63)
Organic Chemicals (19)
Others (7)
Reagent (2)
Basic Inorganic Chemicals (2)
Plant Extract (1)
Materials (1)

Basic Information

Molecular Structure:
CAS No.:	94-78-0
Name:	3-(PHENYLAZO)-2,6-PYRIDINEDIAMINE
Article Data:	8

Formula:	C₁₁H₁₁N₅
Molecular Weight:	213.242
Synonyms:	2,6-Pyridinediamine,3-(phenylazo)- (9CI);Pyridine, 2,6-diamino-3-(phenylazo)- (6CI,7CI,8CI);2,6-Diamino-3-phenylazopyridine;Gastracid;Gastrotest;NSC 145895;Phenazopyridine;3-Phenylazopyridine-2,6-diamine;
EINECS:	202-363-2
Density:	1.32 g/cm³
Melting Point:	139 °C
Boiling Point:	442.3 °C at 760 mmHg
Flash Point:	221.3 °C
Solubility:	904.20g/L(25 oC)
Appearance:	dark red to violet crystalline powder
PSA:	89.65000
LogP:	3.82380

Synthetic route

: 108-24-7
acetic anhydride

: 94-78-0
phenazopyridine

: 5222-90-2
2,6-bis-acetylamino-3-phenylazo-pyridine

Conditions

Conditions	Yield
With pyridine at 20℃;	88%

: 108-24-7
acetic anhydride

: 94-78-0
phenazopyridine

A: N-(6-amino-3-phenylazo-pyridin-2-yl)-acetamide

B: 5222-90-2
2,6-bis-acetylamino-3-phenylazo-pyridine

Conditions

Conditions	Yield
With pyridine at 20℃; for 3h;	A 79% B 12%

...Expand

Total:77 Page 1 of 3 1 2 3 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 94-78-0

Consensus Reports

IARC Cancer Review: Animal Inadequate Evidence IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man . 8 ,1975,p. 117.(World Health Organization, Internation Agency for Research on Cancer,Lyon, France.: ) (Single copies can be ordered from WHO Publications Centre U.S.A., 49 Sheridan Avenue, Albany, NY 12210) .

Specification

The 2,6-Pyridinediamine,3-(2-phenyldiazenyl)-, with the CAS registry number 94-78-0, is also known as 2,6-Diamino-3-phenylazopyridine. It belongs to the product categories of Aromatics; Bases & Related Reagents; Heterocycles; Intermediates & Fine Chemicals; Nucleotides; Pharmaceuticals. Its EINECS number is 202-363-2. This chemical's molecular formula is C₁₁H₁₁N₅ and molecular weight is 213.24. What's more, its systematic name is 3-phenylazopyridine-2,6-diamine. Its classification codes are: (1)Drug / Therapeutic Agent; (2)Tumor data. It is a local anesthetic that has been used in urinary tract disorders. Its use is limited by problems with toxicity (primarily blood disorders) and potential carcinogenicity.

Physical properties of 2,6-Pyridinediamine,3-(2-phenyldiazenyl)- are: (1)ACD/LogP: 2.94; (2)# of Rule of 5 Violations: 0; (3)ACD/LogD (pH 5.5): 2.9; (4)ACD/LogD (pH 7.4): 2.94; (5)#H bond acceptors: 5; (6)#H bond donors: 4; (7)#Freely Rotating Bonds: 2; (8)Polar Surface Area: 89.65 Å²; (9)Index of Refraction: 1.687; (10)Molar Refractivity: 61.13 cm³; (11)Molar Volume: 160.3 cm³; (12)Polarizability: 24.23×10^-24cm³; (13)Surface Tension: 58.2 dyne/cm; (14)Density: 1.32 g/cm³; (15)Flash Point: 221.3 °C; (16)Enthalpy of Vaporization: 69.97 kJ/mol; (17)Boiling Point: 442.3 °C at 760 mmHg; (18)Vapour Pressure: 5.1E-08 mmHg at 25°C.

You can still convert the following datas into molecular structure:
(1)SMILES: Nc2nc(N)ccc2N=Nc1ccccc1
(2)Std. InChI: InChI=1S/C11H11N5/c12-10-7-6-9(11(13)14-10)16-15-8-4-2-1-3-5-8/h1-7H,(H4,12,13,14)
(3)Std. InChIKey: QPFYXYFORQJZEC-UHFFFAOYSA-N

The toxicity data is as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
man	TDLo	oral	4693mg/kg/3Y- (4693mg/kg)	KIDNEY, URETER, AND BLADDER: OTHER CHANGES IN URINE COMPOSITION BLOOD: METHEMOGLOBINEMIA-CARBOXYHEMOGLOBIN SKIN AND APPENDAGES (SKIN): NAILS: OTHER	Annals of Internal Medicine. Vol. 127, Pg. 1137, 1997.
mouse	LD50	oral	580mg/kg (580mg/kg)		Pharmaceutica Acta Helvetiae. Vol. 35, Pg. 423, 1960.
rat	LD50	intraperitoneal	560mg/kg (560mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: STRUCTURAL OR FUNCTIONAL CHANGE IN TRACHEA OR BRONCHI LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Journal of Pharmacology and Experimental Therapeutics. Vol. 51, Pg. 200, 1934.